Summary
The effects of 1,25-dihydroxy vitamin D3 [1,25(OH)2D3], prostaglandin (PGE2), and osteoclast-activating factor (OAF) on the size of osteoclasts, nuclei, ruffled borders, and clear zones in cultured long bones of fetal rats were quantitated. In addition, the number of osteoclasts in the bones was counted and the release of calcium from the bone into the culture medium was determined. These data were compared with the corresponding effects of parathyroid hormone (PTH). All agents tested increased the size of the ruffled borders significantly after 3 h, the size of the clear zones after 12 h, and the size of the cells after 12–24 h. No important differences in sizes were noticed between the agents tested or between the agents and PTH. The number of osteoclasts was increased after 24 h of treatment with PTH, but not after the other agents. Calcium release was significantly increased for all agents between 12 and 24 h. It is concluded that bone resorption by 1,25(OH)2D3, OAF, and PGE2 is mediated primarily by increased activity of existing osteoclasts similar to PTH activation.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
King, G.J., Holtrop, M.E., Raisz, L.G.: The relation of ultrastructural changes in osteoclasts to resorption in bone cultures stimulated with parathyroid hormone, Metab. Bone Dis. Rel. Res.1:67–74, 1978
Holtrop, M.E., King, G.J., Cox, K.A., Reit, B.: Time-related changes in the ultrastructure of osteoclasts after injection of parathyroid hormone in young rats, Calcif. Tissue Int.27:129–135, 1979
Raisz, L.G., Trummel, C.L., Holick, M.F., De Luca, H.F.: 1,25-Dihydroxycholecalciferol: a potent stimulator of bone resorption in tissue culture, Science175:768–769, 1972
Reynolds, J.J., Holick, M.F., De Luca, H.F.: The role of vitamin D metabolites in bone resorption, Calcif. Tissue Res.12:295–301, 1973
Stern, P.H., Mavreas, T., Trummel, C.L., Schnoes, H.K., De Luca, H.F.: Bone-resorbing activity of analogues of 25-hydroxycholecalciferol: effects of side chain modification and stereoisomerization on responses of fetal rat bonesin vitro, Mol. Pharmacol.12:879–886, 1976
Mahgoub, A., Sheppard, H.: Effect of hydroxy-vitamin D3 derivatives on45Ca release from rat fetal bonesin vitro, Endocrinology100:629–634, 1977
Herrmann-Erlee, M.P.M., Gaillard, P.J.: The effects of 1,25-dihydroxycholecalciferol on embryonic bonein vitro: a biochemical and histological study, Calcif. Tissue Res.25:111–118, 1978
Tanaka, Y., De Luca, H.F.: Bone mineral mobilization activity of 1,25-dihydroxycholecalciferol, a metabolite of vitamin D1, Arch. Biochem. Biophys.146:574–578, 1971
Wong, R.G., Myrtle, J.F., Tsai, H.C., Norman, A.W.: The occurrence and biological activity of 1,25-dihydroxy-vitamin D3 in bone, J. Biol. Chem.247:5728–5735, 1972
Castillo, L., Tanaka, Y., De Luca, H.F.: The mobilization of bone mineral by 1,25-dihydroxyvitamin D3 in hypophosphatemic rats, Endocrinology97:995–999, 1975
Klein, D.C., Raisz, L.G.: Prostaglandins: stimulation of bone resorption in tissue culture, Endocrinology86:1436–1440, 1970
Dietrich, J.W., Goodson, J.M., Raisz, L.G.: Stimulation of bone resorption by various prostaglandins in organ culture, Prostaglandins10:231–240, 1975
Horton, J.E., Raisz, L.G., Simmons, H.A., Oppenheim, J.J., Mergenhagen, S.E.: Bone resorbing activity in supernatant fluid from cultured human peripheral blood leukocytes, Science177:793–795, 1972
Raisz, L.G., Luben, R.A., Mundy, G.R., Dietrich, J.W., Horton, J.E., Trummel, C.L.: Effect of osteoclast activating factor from human leukocytes on bone metabolism, J. Clin. Invest.56:408–413, 1975
Raisz, L.G., Niemann, I.: Effect of phosphate, calcium, and magnesium on bone resorption and hormonal responses in tissue culture, Endocrinology85:446–452, 1969
Holtrop, M.E., Raisz, L.G., Simmons, H.A.: The effects of parathyroid hormone, colchicine, and calcitonin on the ultrastructure and the activity of osteoclasts in organ culture, J. Cell Biol.60:346–355, 1974
Holtrop, M.E.: Quantitation of the ultrastructure of the osteoclast for the evaluation of cell function. In P.J. Meunier (ed.): Proc. Second Int. Wkshp. Bone Histomorphometry, pp. 133–145. Armour Montagu, Paris, 1977
Weisbrode, S.E., Capen, C.C., Nagode, L.A.: Ultrastructural evaluation of the effects of vitamin D and uremia on bone in the rat, Am. J. Pathol.76:359–369, 1974
Galasko, C.S.B.: Mechanisms of bone destruction in the development of skeletal metastases, Nature263:507–508, 1976
Mundy, G.R., Raisz, L.G., Copper, R.A., Schechter, G.P., Salmon, S.E.: Evidence for the secretion of an osteoclast stimulating factor in myeloma, N. Engl. J. Med.291:1041–1046, 1974
Weber, J.C., Pons, V., Kodicek, E.: The localization of 1,25-dihydroxycholecalciferol in bone cell nuclei of rachitic chicks, Biochem. J.125:147–153, 1971
Kream, B.E., Jose, M., Yamada, S., De Luca, H.F.: A specific high affinity binding macromolecule for 1,25-dihydroxyvitamin D3 in fetal bone, Science197:1086–1088, 1977
Franklin, R.B., Tashjian, A.H., Intravenous infusion of prostaglandin E2 raises plasma calcium concentration in the rat, Endocrinology97:240–243, 1975
Goodson, J.M., McClatchy, K., Revell, C.: Prostaglandin-induced resorption of the adult rat calvarium, J. Dent. Res.53:670–677, 1974
Galasko, C.S.B., Bennett, A.: Relationship of bone destruction in skeletal metastases to osteoclast activation and prostaglandins, Nature263:508–510, 1976
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Holtrop, M.E., Raisz, L.G. Comparison of the effects of 1,25-dihydroxycholecalciferol, prostaglandin E2, and osteoclast-activating factor with parathyroid hormone on the ultrastructure of osteoclasts in cultured long bones of fetal rats. Calcif Tissue Int 29, 201–205 (1979). https://doi.org/10.1007/BF02408081
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02408081